Literature DB >> 25857454

The orexin 1 receptor modulates kappa opioid receptor function via a JNK-dependent mechanism.

James D Robinson1, Patricia H McDonald2.   

Abstract

The orexin 1 receptor (OX1R) and the kappa opioid receptor (KOR) are two G protein-coupled receptors (GPCRs) previously demonstrated to play important roles in modulating the rewarding effects of drugs of abuse such as cocaine. Using cells heterologously expressing both receptors, we investigated whether OX1R can regulate the function of KOR and vice versa. Activation of OX1R was found to attenuate agonist-activated KOR-mediated inhibition of cAMP production. In contrast, agonist-activated KOR-mediated β-arrestin recruitment and p38 activation were enhanced in the presence of activated OX1R. These effects are independent of OX1R internalization but are blocked in the presence of the JNK inhibitor SP-600125. OX1R signaling does not affect ligand binding by KOR. Taken together, these data suggest that OX1R signaling can modulate KOR function in a JNK-dependent manner, promoting preferential signaling of KOR via β-arrestin/p38 rather than Gαi. Conversely, Gαq coupling of OX1R is unaffected by activation of KOR, suggesting that this crosstalk is unidirectional. Given that KOR Gαi-mediated signaling events and β-arrestin-mediated signaling events are thought to promote distinct cellular responses and physiological outcomes downstream of KOR activation, this mechanism may have important implications on the behavioral effects of KOR activity.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Keywords:  Crosstalk; Dynorphin; GPCR; JNK; Orexin

Mesh:

Substances:

Year:  2015        PMID: 25857454      PMCID: PMC5549559          DOI: 10.1016/j.cellsig.2015.03.026

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  33 in total

Review 1.  The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.

Authors:  Sunmee Wee; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2010-03-30       Impact factor: 4.530

2.  Chemotype-selective modes of action of κ-opioid receptor agonists.

Authors:  Eyal Vardy; Philip D Mosier; Kevin J Frankowski; Huixian Wu; Vsevolod Katritch; Richard B Westkaemper; Jeffrey Aubé; Raymond C Stevens; Bryan L Roth
Journal:  J Biol Chem       Date:  2013-10-11       Impact factor: 5.157

3.  Neurons containing hypocretin (orexin) project to multiple neuronal systems.

Authors:  C Peyron; D K Tighe; A N van den Pol; L de Lecea; H C Heller; J G Sutcliffe; T S Kilduff
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

4.  Identification of novel functionally selective κ-opioid receptor scaffolds.

Authors:  Kate L White; Alex P Scopton; Marie-Laure Rives; Ruslan V Bikbulatov; Prabhakar R Polepally; Peter J Brown; Terrance Kenakin; Jonathan A Javitch; Jordan K Zjawiony; Bryan L Roth
Journal:  Mol Pharmacol       Date:  2013-10-10       Impact factor: 4.436

5.  Differential effects of the Gβ5-RGS7 complex on muscarinic M3 receptor-induced Ca2+ influx and release.

Authors:  Darla Karpinsky-Semper; Claude-Henry Volmar; Shaun P Brothers; Vladlen Z Slepak
Journal:  Mol Pharmacol       Date:  2014-02-28       Impact factor: 4.436

Review 6.  Control of arousal by the orexin neurons.

Authors:  Chloe Alexandre; Mark L Andermann; Thomas E Scammell
Journal:  Curr Opin Neurobiol       Date:  2013-05-15       Impact factor: 6.627

7.  Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking.

Authors:  Benjamin B Land; Michael R Bruchas; Selena Schattauer; William J Giardino; Megumi Aita; Daniel Messinger; Thomas S Hnasko; Richard D Palmiter; Charles Chavkin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-28       Impact factor: 11.205

8.  Adenosine A2a receptors induce heterologous desensitization of chemokine receptors.

Authors:  Ning Zhang; De Yang; Huifang Dong; Qian Chen; Dessislava I Dimitrova; Thomas J Rogers; Michail Sitkovsky; Joost J Oppenheim
Journal:  Blood       Date:  2006-03-07       Impact factor: 22.113

9.  Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area.

Authors:  John W Muschamp; Jonathan A Hollander; Jennifer L Thompson; George Voren; Linda C Hassinger; Sara Onvani; Theodore M Kamenecka; Stephanie L Borgland; Paul J Kenny; William A Carlezon
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-24       Impact factor: 11.205

10.  Hypocretin-1 receptors regulate the reinforcing and reward-enhancing effects of cocaine: pharmacological and behavioral genetics evidence.

Authors:  Jonathan A Hollander; Don Pham; Christie D Fowler; Paul J Kenny
Journal:  Front Behav Neurosci       Date:  2012-07-24       Impact factor: 3.558

View more
  9 in total

1.  Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol.

Authors:  Rachel I Anderson; David E Moorman; Howard C Becker
Journal:  Handb Exp Pharmacol       Date:  2018

2.  Opioid receptors signaling network.

Authors:  Lathika Gopalakrishnan; Oishi Chatterjee; Namitha Ravishankar; Sneha Suresh; Rajesh Raju; Anita Mahadevan; T S Keshava Prasad
Journal:  J Cell Commun Signal       Date:  2021-11-01       Impact factor: 5.908

Review 3.  Orexin Signaling: A Complex, Multifaceted Process.

Authors:  Natasha C Dale; Daniel Hoyer; Laura H Jacobson; Kevin D G Pfleger; Elizabeth K M Johnstone
Journal:  Front Cell Neurosci       Date:  2022-04-13       Impact factor: 6.147

4.  Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress.

Authors:  Abigail M Polter; Kelsey Barcomb; Rudy W Chen; Paige M Dingess; Nicholas M Graziane; Travis E Brown; Julie A Kauer
Journal:  Elife       Date:  2017-04-12       Impact factor: 8.140

Review 5.  G Protein-Coupled Receptor Systems and Their Role in Cellular Senescence.

Authors:  Paula Santos-Otte; Hanne Leysen; Jaana van Gastel; Jhana O Hendrickx; Bronwen Martin; Stuart Maudsley
Journal:  Comput Struct Biotechnol J       Date:  2019-08-23       Impact factor: 7.271

6.  κ-Opioid Signaling in the Lateral Hypothalamic Area Modulates Nicotine-Induced Negative Energy Balance.

Authors:  Patricia Seoane-Collazo; Amparo Romero-Picó; Eva Rial-Pensado; Laura Liñares-Pose; Ánxela Estévez-Salguero; Johan Fernø; Rubén Nogueiras; Carlos Diéguez; Miguel López
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

7.  Orexin Receptor Multimerization versus Functional Interactions: Neuropharmacological Implications for Opioid and Cannabinoid Signalling and Pharmacogenetics.

Authors:  Miles D Thompson; Takeshi Sakurai; Innocenzo Rainero; Mary C Maj; Jyrki P Kukkonen
Journal:  Pharmaceuticals (Basel)       Date:  2017-10-08

8.  Peroxiredoxin 6 mediates Gαi protein-coupled receptor inactivation by cJun kinase.

Authors:  Selena S Schattauer; Benjamin B Land; Kathryn L Reichard; Antony D Abraham; Lauren M Burgeno; Jamie R Kuhar; Paul E M Phillips; Shao En Ong; Charles Chavkin
Journal:  Nat Commun       Date:  2017-09-29       Impact factor: 14.919

Review 9.  The role of co-neurotransmitters in sleep and wake regulation.

Authors:  Jun Oh; Cathrine Petersen; Christine M Walsh; Jackson C Bittencourt; Thomas C Neylan; Lea T Grinberg
Journal:  Mol Psychiatry       Date:  2018-10-30       Impact factor: 15.992

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.